Mederi sponsored a great booth presentation at this SAGES meeting. During the presentation, Stretta was introduced as a safe and effective treatment for chronic gastroesophageal reflux disease (GERD) in bariatric patients during the SAGES Welcome Reception Wednesday evening, April 15, 2015. The presentation was led by Dana Portenier, MD, Program Director of Duke Minimally Invasive and Bariatric Surgery at Duke University Medical Center. Duke has introduced Stretta Therapy into their program to treat bariatric patients, whose altered anatomies limit their treatment options when chronic GERD symptoms are present post-bariatric procedures. Because Stretta is non-surgical, delivered through the mouth, and does not alter the anatomy, it is an ideal treatment option to provide relief from GERD symptoms in the bariatric patient. It is an alternative that permits further surgery if necessary, and leaves the gastric sleeve or Roux-En-Y anatomy unaffected.
In addition, data from a recently published animal study that defined the mechanism of action for both Stretta and Secca therapies, was presented.
The Key is How NARF Works
A recent animal study published online in Colorectal Disease, showed that the effect of radiofrequency at the levels delivered by Stretta and Secca to the smooth muscle of the GI tract, is non-ablative and actually improves and regenerates the structure of the muscle. These findings may explain why these therapies are so versatile and have value for both standard and difficult to treat patients.
Dr. Steven Wexner, Director of the Digestive Disease Center and Chairman of the Department of Colorectal Surgery at Cleveland Clinic Florida, presented clinical data on Secca therapy for fecal incontinence, and Dr. Mariana Berho, Director of the Pathology and Laboratory Medicine Center and of the Center for Research at Cleveland Clinic Florida presented findings from this randomized animal study that examined the impact of non-ablative radiofrequency (NARF) on smooth muscle at the cellular level.
SAGES 2015 – STRETTA FOR BARIATRIC GERD PRESENTATION
http://youtu.be/8JqNvg5TRJ8
SAGES 2015 – SECCA FOR FECAL INCONTINENCE PRESENTATION
http://youtu.be/PPCESTDabr0
SAGES 2015 – MECHANISM OF NARF PRESENTATION
http://youtu.be/BnVq5nYeil4
Bree has been an integral part of Restech from the very beginning. She holds a Masters in Public Health from George Washington University, a BFA from The University of Kansas in Visual Communications, and is a National Board Certified Health & Wellness Coach. Her command of marketing, public health/health delivery systems, and human health behavior change gives her a unique perspective in developing effective marketing strategies for the company.
Physicians: Fill out the form below to complete your request to be added to the “Find-A-Doctor” map on restech.com
Thomas previously worked as a polysomnographic technologist in the Virginia Mason system, before moving into sales with Restech in 2007. After spending 9 years working with distributors across Europe, he was moved into an organizational role at the head office in Houston. In this capacity he works closely with sales and marketing to provide clinical support, manages clinical studies, and provides clinical perspectives on business development. In his spare time Thomas plays rugby for Houston Athletic Rugby Club.
Jeff has over 30 years of experience in the medical device industry and previously worked in sales at companies such as Encision Inc., Interventional Therapies, LLC, Boston Scientific, and United States Surgical Corporation. He has been working as the VP of Sales for Mederi Therapeutics since 2009 and now brings his extensive expertise to Restech. Jeff was part of the team that bridged the Mederi asset sale to Restech. His clinical knowledge of the Stretta and Secca technologies is invaluable. Jeff has three decades of physician relations experience that he brings to Restech as part of the leadership team.
Ray joined Restech in May 2018 as the Vice President for Sales. He has been in the medical device, and specifically in the GERD space for more than 18 years. Starting in sales at Sandhill Scientific pH diagnostics, he moved on to Curon Medical when Stretta and Secca were first introduced to the market. He then worked for Given Imaging when Curon closed operations. When Stretta was relaunced he joined Mederi as VP of Sales. Ray was instrumental in keeping Stretta alive and the customer based informed when Mederi ceased operation and assets were purchased by Restech. He is part of the leadership team directing all product sales for Restech. Ray graduated from Old Dominion University in Norfolk with a BS in Marketing and Business Administration.
Mark is a seasoned professional and Certified Public Accountant in Texas who brings a unique blend of creative vision and financial expertise to any leadership team. He worked as a Senior Executive for 15 years on a leadership team which grew a private equity backed cash logistics company performing at negative EBITDA on $100 million revenue into an international industry leader with superior profitability on revenue exceeding $1.5 billion. In addition, he spent 10 years as a Senior Manager at Price Waterhouse delivering results-oriented merger & acquisition, audit and strategic consulting services to middle market clientele including over 40 manufacturing, distribution, service, nonprofit and technology clients. Mark currently serves as a Chief Financial Officer and consulting CFO (seven years) providing in-house and outsourced CFO and transactional services to the middle market.
Larry is the CTO for Restech and holds a B.S. in Computer Science. He is a software architect specializing in remote patient monitoring, medical sensors, and clinical trial software. Larry holds a patent on massively distributed computing and has worked for a number of major software startup companies including Sybase, Oracle, and Teradata. Larry was also the co-founder of a startup to deliver advanced clinical pathways to patients using mobile devices and medical sensors. Larry is truly a pioneer and now a veteran in the deployment.
Jeff has a breadth of experience with over 25 years in engineering and executive positions within major fortune 100 healthcare companies. He also has proven success in startup medical technology companies. Jeff provides leadership in securing and managing Restech’s patent portfolio. He also built Restech’s compliance platform that established regulatory acceptance in 25+ countries worldwide. Jeff’s scientific support and in-depth understanding of the device industry set the foundation for current and future commercial innovations at Restech.
With nearly 30 years of working with physician thought leaders developing novel and emerging technologies, Leo has played a key role in the development and evolution of balloon angioplasty and stent technologies that revolutionized the therapy of cardiac disease. His experience was instrumental in the development of the patented platform technology which drives the Restech sensor. Leo provides a vision and passion for effecting change in the diagnosis and management of atypical reflux.
With over 20 years of executive experience in both the private and public sector, Debra brings a broad understanding of healthcare delivery system. With experience managing products aimed at wide scale disease and population management for 20 million subscribers, Debra has extensive experience in effectively and efficiently developing models of delivery that address specific health issues. Debra has also been involved in the legislative process and served as the elected President of the Independent Physician Association of California. Debra is dedicated to bringing tools to the healthcare market that improve and support the clinical process.